# A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

> **NCT03980756** · PHASE1 · COMPLETED · sponsor: **Addpharma Inc.** · enrollment: 88 (actual)

## Conditions studied

- Gastritis

## Interventions

- **DRUG:** AD-206 20mg
- **DRUG:** Esomeprazole 20mg
- **DRUG:** AD-206 40mg
- **DRUG:** Esomeprazole 40mg

## Key facts

- **NCT ID:** NCT03980756
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-05
- **Primary completion:** 2020-04-27
- **Final completion:** 2020-06-18
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03980756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03980756, "A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03980756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*